iShares Trust iShares 20+ Year Treasury Bond BuyWrite Strategy ETF (BATS: TLTW)

Latest news for iShares Trust iShares 20+ Year Treasury Bond BuyWrite Strategy ETF (BATS:TLTW)

The Fund seeks to track the investment results of the Cboe TLT 2 Percent OTM BuyWrite Index (the Underlying Index), which is provided by Cboe Global Indices, LLC (the Index Provider or Cboe) and is designed to measure the performance of a strategy of holding the Underlying Fund while writing (selling) one-month call options on the Underlying Fund to generate income. A strategy of holding a stock or basket of stocks and selling call options that reference the stock or basket of stocks is commonly known as a covered call or buy-write strategy.

Bonds Ishares 20+ Yr Treasury Bd ETF

Blackrock Cash Funds: Treasury, Sl Agency Shares

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF

Long Ideas

News

Broad U.S. Equity ETFs

Short Ideas

Specialty ETFs

New ETFs

Offerings

Trading Ideas

ETFs

iShares Trust iShares High Yield Corporate Bond BuyWrite Strategy ETF

HYGW

iShares Trust iShares Investment Grade Corporate Bond BuyWrite Strategy ETF

LQDW

iShares Trust Barclays 20+ Year Treasury Bond Fund

iShares Trust iShares 20+ Year Treasury Bond BuyWrite Strategy ETF

TLTW

On August 22, BlackRock Inc (NYSE: BLK) unveiled three new fixed income exchange traded funds, offering investors a BuyWrite strategy on fixed income assets.

BlackRock Announces 3 New BuyWrite Fixed Income ETFs For The Savvy Investor

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Pyxis Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYXS#NASDAQ">PYXS</a>) with a Buy and maintains $7 price target.

Price Target

Reiteration

Analyst Ratings

PYXS

HC Wainwright & Co. Reiterates Buy on Pyxis Oncology, Maintains $7 Price Target

On Wednesday, November 20, U.S. markets closed mixed. The Nasdaq slipped, weighed down by geopolitical tensions and Target&#8217;s disappointing performance. Nvidia declined ahead of earnings, which later underwhelmed. Meanwhile, the Dow edged higher, and the S&amp;P 500 remained flat.
In economic data, U.S. mortgage applications increased by 1.7% for the week ending November 15, up from the 0.5% rise recorded the previous week.
Healthcare, energy, and materials led S&amp;P 500 gains Wednesday, while consumer discretionary and financials declined.
The Dow Jones Industrial Average was up 0.32% and closed at 43,408.47, the S&amp;P 500 gained 0.002% to 5,917.11, and the Nasdaq Composite declined 0.11% to finish at 18,966.14.
Asia Markets Today
<ul>
<li>On Thursday, Japan&#8217;s Nikkei 225 declined 0.97% and ended the session at 38,002.50, led by losses in the Insurance, Transportation Equipment, and Power sectors.</li>
<li>Australia&#8217;s S&amp;P/ASX 200 fell 0.04% and ended the day at 8,323.00, led by losses in the Consumer Discretionary, Consumer Staples, and A-REITs sectors.</li>
<li>India&#8217;s Nifty 50 declined 0.73% to 23,346.70, and Nifty 500 slid 0.85% closing at 21,816.45, led by losses in the Public Sector Undertakings, Oil &amp; Gas and Power sectors.</li>
<li>China&#8217;s Shanghai Composite gained 0.07% to close at 3,370.40, and the Shenzhen CSI 300 rose 0.09%, finishing the day at 3,989.30.</li>
<li>Hong Kong&#8217;s Hang Seng fell 0.53% and closed the session at 19,601.11.</li>
</ul>
Eurozone at 05:30 AM ET
<ul>
<li>The European STOXX 50 index was down 0.36%.</li>
<li>Germany&#8217;s DAX slid 0.02%.</li>
<li>France&#8217;s CAC declined 0.43%.</li>
<li>FTSE 100 index traded higher by 0.20%</li>
</ul>
Commodities at 05:30 AM ET
<ul>
<li>Crude Oil WTI was trading higher by 1.70% at $69.94/bbl, and Brent was up 1.58% at $73.95/bbl.</li>
<li>Oil prices rose amid escalating Russia-Ukraine missile strikes, overshadowing a larger-than-expected U.S. crude inventory increase.</li>
<li>Natural Gas rose 6.45% to $3.297.</li>
<li>Gold was trading higher by 0.78% at $2,672.45, Silver was up 0.35% to $31.115, and Copper fell 0.83% to $4.1210.</li>
</ul>
U.S. Futures at 05:30 AM ET
Dow futures declined 0.07%, S&amp;P 500 futures were down 0.24% and Nasdaq 100 futures fell 0.35%.
Forex at 05:30 AM ET
The U.S. dollar index gained 0.04% to 106.72, the USD/JPY was down 0.64% to 154.44, and the USD/AUD slid 0.08% to 1.5357.
Photo by Pavel Bobrovskiy via Shutterstock

Asia

Emerging Markets

Eurozone

Futures

Commodities

Forex

Markets

ADIV

AGOV

ASHR

BBEU

BOIL

CQQQ

PowerShares DBmmodity Index Optimum Yield Diversified Fund

EEMA

FLAX

CurrencyShares British Pound Sterling Trust

IEMG

IEUR

KraneShares Trust KraneShares S&P Pan Asia Dividend Aristocrats Index ETF

KDIV

SPEM

USDU

PowerShares DB US Dollar Index Bullish Fund

Asia And Europe Markets Mixed; Dollar Hovers Near 52-Week High - Global Markets Today While US Slept

Throughout this NFL-style, three-day combine, prospects from nearly every state are expected to attend, with this year's event expected to host the largest total number of recruits in the event's history and the largest combine-style event in the country.
In connection with their participation in the event, all student-athletes will receive a complimentary one-month trial of the Signing Day Sports app, enhancing their visibility to college recruiters.
By collecting registration fees and offering exclusive apparel for participants and fans, the combine enables the Company to drive immediate income while strengthening its brand presence.&nbsp;
&nbsp;

Signing Day Sports Provides Update On Upcoming 3rd Annual US Army Bowl National Combine; Says Combine Enables Company To Drive Immediate Income While Strengthening Its Brand Presence

China Renaissance analyst Yiwen Zhang downgrades Grab Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRAB#NASDAQ">GRAB</a>) from Buy to Hold and announces $5.4 price target.

Downgrades

GRAB

China Renaissance Downgrades Grab Holdings to Hold, Announces $5.4 Price Target

HC Wainwright &amp; Co. analyst Joseph Pantginis reiterates Lisata Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSTA#NASDAQ">LSTA</a>) with a Buy and maintains $15 price target.

LSTA

HC Wainwright & Co. Reiterates Buy on Lisata Therapeutics, Maintains $15 Price Target

Needham analyst Mike Cikos maintains Snowflake (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SNOW#NYSE">SNOW</a>) with a Buy and raises the price target from $160 to $200.

SNOW

Needham Maintains Buy on Snowflake, Raises Price Target to $200

<ul>
<li>Aphexda is Biolinerx's FDA-Approved Stem Cell Mobilization Agent Indicated In Combination With Filgrastim For Collection And Subsequent Autologous Transplantation In Patients With Multiple Myeloma.</li>
<li>BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as royalties on net sales ranging from 18% to 23%.</li>
<li>BioLineRx retains rights to develop and commercialize motixafortide in solid tumors, including PDAC.</li>
<li>BioLineRx received $9 million equity investment from certain funds managed by Highbridge Capital Management, LLC to support company's pipeline and expansion.</li>
<li>Transactions enable significant reduction in BioLineRx's operational expenses and debt, and allow the company to focus on development activities in areas of high unmet need in oncology and rare diseases –</li>
</ul>

Biotech

Health Care

Contracts

General

BLRX

BioLineRx And Ayrmid Entered Into A License Agreement For Motixafortide (Commercially Sold In The US As Aphexda), BioLineRx Will Receive A $10M Upfront Payment And Is Also Eligible To Receive Up To An Additional $87M Of Potential Commercial Milestones, Plus Royalties Between 18%-23% On Net Sales Of Aphexda

Trimble will provide fleet management and telematics solutions to vehicles across PFG's three business segments including Performance Foodservice Core-Mark and Vistar.&nbsp;
All PFG vehicles will be equipped with Trimble Instinct, Trimble's in-cab ecosystem that seamlessly connects drivers and back-office staff to boost safety, compliance and efficiency.
 &nbsp;

PFGC

TRMB

Performance Food Group Selects Trimble As Its Premier Fleet Management Provider; Migrates 100% Of Its Fleet Management Business To Trimble Instinct, Doubling Trimble-Serviced Trucks To Over 8,000

Earnings

Citigourp Global Markets 2% Protected Notes Linked To The Djia

PDD Holdings Q3 Adj EPADS $2.65 Misses $2.82 Estimate, Sales $14.16B Miss $14.47B Estimate

Artificial intelligence (AI) darling Nvidia Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) <a href="https://www.benzinga.com/news/earnings/24/11/42099904/nvidia-beats-q3-revenue-eps-estimates-supply-constraints-ding-stock-huang-says-age-of-ai-is-in-full-steam">beat expectations yet again</a> with impressive third-quarter revenue and earnings reported after Wednesday's market close. 
What happened: The world's most valuable company <a href="https://www.benzinga.com/24/11/42099904/nvidia-q3-earnings-highlights">disclosed </a>third-quarter revenue of $35.1 billion and earnings per share of 81 cents, both beating analysts' estimates.&nbsp;
The Jensen Huang-led firm has had a blockbuster run on equity markets in the last few years, multiplying investors' money by orders of magnitude.&nbsp;
Indeed, Nvidia shares have exploded by 2,718% in the last five years, outperforming all well-known companies on Wall Street.
In comparison, Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>)—the world's most valued cryptocurrency exerting a similar influence on the digital assets market—grew 1,171% over the last five years.
See Also: <a href="https://www.benzinga.com/24/11/42079799/microstrategys-michael-saylor-to-advocate-for-bitcoin-investment-at-microsoft-board-meeting-offers-to-educate-rumble-ceo-with-the-strategy">Microstrategy&#8217;s Michael Saylor To Advocate For Bitcoin At Microsoft Board Meeting, Offers To Educate Rumble CEO As Well</a>
<h2 class="wp-block-heading">Which Is Offering Better Returns Relative To Risk?</h2>
Both Nvidia and Bitcoin are risk-laden investments, and traders must navigate their inherent volatility to profit.
To get a more accurate picture, analysts track the Sharpe Ratio, a measure of risk-adjusted returns. 
For Bitcoin, this ratio stood at -5 as of this writing, <a href="https://in.tradingview.com/chart/XlzxagWe/?symbol=BITSTAMP%3ABTCUSD">per </a>TradingView, implying that the expected return was lower than that of a risk-free investment, such as a Treasury yield.&nbsp;
On the other hand, Nvidia <a href="https://www.tradingview.com/chart/XlzxagWe/?symbol=NASDAQ%3ANVDA">showed </a>a Sharpe ratio of 0.69, indicating that investment in the stock was generating positive returns above the risk-free rate.
<h2 class="wp-block-heading">Are Their Valuations Inflated?</h2>
Another metric to compare the two hot financial assets was whether they were expensive or cheap relative to their fundamentals.
For stocks, this is typically measured by the price-to-earnings ratio, or simply the P/E ratio.&nbsp;
Nvidia's P/E ratio showed a reading of 73.478 per TradingView, suggesting that the stock was highly overpriced. It could also imply that investors expect the company to have stronger performance and higher earnings in the future.
The P/E counterpart for Bitcoin is the network value to transactions ratio or NVT ratio.
According to on-chain analytics firm <a href="https://cryptoquant.com/asset/btc/chart/network-indicator/nvt-ratio?window=DAY&amp;sma=0&amp;ema=0_30&amp;priceScale=log&amp;metricScale=log&amp;chartStyle=column">CryptoQuant</a>, the 30-day EMA of Bitcoin's NVT was at 28.28 at the time of writing, a decline from 36.32 recorded at the beginning of the month.
The decline implied that transaction volume was outperforming market growth or that valuation had dropped without any change in transaction activity.
Price Action: At the time of writing, Bitcoin was trading at $97,396.60, rising 4.97% in the last 24 hours, according to <a href="https://pro.benzinga.com/dashboard?_gl=1&#x2A;380nj0&#x2A;_ga&#x2A;MTEyOTAyOTcxMy4xNzEzMzY0NTYy&#x2A;_ga_V7ZK73W7N0&#x2A;MTcxNDk4MzIzMi42LjEuMTcxNDk4OTE0Ni4wLjAuMA..">data from Benzinga Pro</a>. Shares of Nvidia were down 2.49% in after-hours trading.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/trading-ideas/movers/24/11/42079984/dogecoin-bitcoin-left-in-the-dust-by-ai-meme-coin-goat-as-nvidias-q3-earnings-draw-near">Dogecoin, Bitcoin Left In The Dust By AI Meme Coin GOAT As Nvidia&#8217;s Q3 Earnings Draw Near</a></li>
</ul>
Photos courtesy: Nvidia and Pixabay

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Tech

$BTC

NVDA

Nvidia Vs. Bitcoin: Jensen Huang-Led Chip Giant's Stock Outperformed The Top Cryptocurrency Over 5 Years. Here's How They Compare On Other Metrics

Benchmark analyst Cody Acree maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $170 to $190.

Benchmark Maintains Buy on NVIDIA, Raises Price Target to $190

Roth MKM analyst Joe Reagor initiates coverage on Stardust Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SDST#NASDAQ">SDST</a>) with a Buy rating and announces Price Target of $13.

Initiation

SDST

Roth MKM Initiates Coverage On Stardust Power with Buy Rating, Announces Price Target of $13

Morgan Stanley analyst James Faucette upgrades Evertec (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EVTC#NYSE">EVTC</a>) from Underweight to Equal-Weight and raises the price target from $33 to $35.

Upgrades

EVTC

Morgan Stanley Upgrades Evertec to Equal-Weight, Raises Price Target to $35

Morgan Stanley analyst Brian Wilczynski initiates coverage on UMB Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UMBF#NASDAQ">UMBF</a>) with a Overweight rating and announces Price Target of $156.

UMBF

Morgan Stanley Initiates Coverage On UMB Financial with Overweight Rating, Announces Price Target of $156

Needham analyst Quinn Bolton maintains NVIDIA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NVDA#NASDAQ">NVDA</a>) with a Buy and raises the price target from $145 to $160.

Needham Maintains Buy on NVIDIA, Raises Price Target to $160

Morgan Stanley analyst Judah Frommer initiates coverage on 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Underweight rating and announces Price Target of $8.

FDMT

Morgan Stanley Initiates Coverage On 4D Molecular Therapeutics with Underweight Rating, Announces Price Target of $8

Morgan Stanley analyst Judah Frommer initiates coverage on Apellis Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APLS#NASDAQ">APLS</a>) with a Equal-Weight rating and announces Price Target of $31.

APLS

Morgan Stanley Initiates Coverage On Apellis Pharmaceuticals with Equal-Weight Rating, Announces Price Target of $31

Quantum-Si Provides Update On Innovation Roadmap & New Development Partnerships; Announces Next-Generation Platinum System, The Platinum Pro, Scheduled To Launch In H1 Of 2025

Guidance

SCVL

Shoe Carnival Lowers FY24 Net Sales Outlook: Sees Revenues Of $1.20B-$1.23B Vs $1.23B Estimate (Prior View:  $1.23B-$1.25B); Company Reiterates FY24 Adjusted EPS Outlook Of $2.60-$2.75 Vs. $2.63 Estimate

With more than a week of deals planned across the entire assortment, Target will offer some of its lowest prices of the season on thousands of items, including up to 50% off tech, apparel, video games, board games, small appliances, luggage, holiday trees and other must-have items for gifting and gathering.

Target Reveals Its Lineup Of Black Friday Deals Available Now Through Nov. 30 Online And In Its Stores

LQDW: The Great Illusion Of 2-Digit Yields

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of $0.22012

TLTW Makes Sense For Income And Rate Cut Speculation

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of $0.2802

Why I'm Adding Quality Bond Funds To My Income Portfolio

TLTW: Covered Call ETF Focusing On Long-Term Treasuries, Strong 14.9% Yield, Risks Abound

U.S. Treasury liquidity shifts to month-end as passive funds dominate: NY Fed research

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of

iShares 20+ Year Treasury Bond BuyWrite Strategy ETF declares monthly distribution of 0.2076

TLTW ETF: Maybe It's Time To Accumulate

DXYN

GBAB

GOVT

PTBD

SCHO

SDHY

SGOV

SPTL

VGIT

VGLT

VGSH

ZROZ

On August 22, BlackRock Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLK#NYSE">BLK</a>) unveiled three new fixed income exchange traded funds, offering investors a BuyWrite strategy on fixed income assets.

BlackRock&rsquo;s New ETFs: The iShares Trust 20+ Year Treasury Bond BuyWrite Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLTW#NYSE">TLTW</a>), iShares High Yield Corporate Bond BuyWrite Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYGW#NYSE">HYGW</a>), and iShares High Yield Corporate Bond BuyWrite Strategy ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQDW#NYSE">LQDW</a>).

The BuyWrite strategy seeks to invest in the selected ETFs by purchasing the underlying asset, while simultaneously writing (selling) a covered call option on that security which expires in 30 days. With the purpose of generating income from the option premiums.

Each month, the current option will be repurchased one business day before expiry, and a new one-month option will be written.

<a href="https://www.benzinga.com/news/small-cap/22/08/28536506/brief-recession-or-complete-economic-collapse-what-these-wall-street-veterans-think">BlackRock&rsquo;s</a> BuyWrite exchange traded funds will seek to pay monthly distributions that include both the option premiums received and the underlying ETF dividends.

During certain market conditions, the BuyWrite strategy tends to enhance and stabilize income, while reducing the overall risk in the portfolio.

When<a href="https://www.benzinga.com/news/22/07/28184530/morgan-stanley-views-differ-from-jpmorgan-on-federal-reserves-policy-outlook-bloomberg"> interest rates</a> rise and the spread widens, BlackRock&rsquo;s BuyWrite Strategy ETFs will outperform the underlying exchange traded funds.

Go To:&nbsp;<a href="https://www.benzinga.com/m-a/22/08/28529951/blackrock-to-pledge-a-1b-in-australian-battery-storage-assets-report">BlackRock To Pledge A$1B In Australian Battery Storage Assets - Report</a>

The underlying exchange traded funds used are the iShares 20+ Year Treasury Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TLT#NYSE">TLT</a>), iShares iBoxx $ High Yield Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HYG#NYSE">HYG</a>), and the iShares iBoxx $ Investment Grade Corporate Bond ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LQD#NYSE">LQD</a>).

Stephen Laipply, U.S. Head of Bond ETFs at BlackRock commented, &ldquo;Our buy-write exposures expand the functionalities of bond ETFs by unlocking a sophisticated use case with a potential to enhance income for investors in this <a href="https://www.benzinga.com/money/most-volatile-stocks/">volatile</a> yield environment.&rdquo;

Comments

iShares Trust iShares 20+ Year Treasury Bond BuyWrite Strategy ETF

News

Latest news for iShares Trust iShares 20+ Year Treasury Bond BuyWrite Strategy ETF (BATS:TLTW)

Tuesday, August 23, 2022

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga